UCERIS: payments to doctors
Payments that named UCERIS as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $101K
- Providers
- 808
- Transactions
- 2,082
- Average per transaction
- $48
The per-transaction average — $48 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 808 providers the average total is $124, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | $100,309 | 99.8% |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | $146 | 0.1% |
| Bausch & Lomb Americas Inc. | $54 | 0.1% |